NYMOX PHARMACEUTICAL CORP

NYMXF · OTCM

CIK 1018735fmd_0YFJA6FKYS5TZS6H3PZK18Z0BNManufacturing · In Vitro & In Vivo Diagnostic SubstancesTemplate: Standard

Coverage: Jan 01, 2015 to Dec 31, 2025, 33 periods

Ratios computed from the standardized statements. Select a value to open its proof.